Evidence map›Paper›PMID 41083965›Full record

ArticleBMC infectious diseases2025

Urine bioassay optimisation to assess the association between antimicrobial exposure, pneumococcal carriage and antimicrobial resistance among hospitalised children in Malawi.

Susann Skovbjerg, Comfort Brown, Andrew A Mataya, Jacquline Msefula, Farouck Bonomali, Faith Banda, Akuzike Kalizang'oma, Robert S Heyderman, Neil French, Todd D Swarthout

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Susann SkovbjergDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden. susann.skovbjerg@vgregion.se.
Comfort BrownMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Andrew A MatayaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Jacquline MsefulaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Farouck BonomaliMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Faith BandaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Akuzike Kalizang'omaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Robert S HeydermanNIHR Global Health Research Unit on Mucosal Pathogens, Research Department of Infection, Division of Infection and Immunity, University College London, London, UK.
Neil FrenchCentre for Global Vaccine Research, Institute of Infection and Veterinary & Ecological Science, University of Liverpool, Liverpool, UK.
Todd D SwarthoutMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding antibiotic exposure in low-income settings is crucial when designing and evaluating field research on bacterial carriage and antimicrobial resistance. We evaluated the concordance between reported pre-hospitalisation antibiotic use and antimicrobial activity in urine from children presented with acute respiratory infection (ARI) at a Malawian referral hospital. We further investigated the association between antibiotic exposure and antibiotic resistance prevalence among nasopharyngeal pneumococci.

methodsBetween November 2016 and July 2019, 102 children aged 1–4 years with ARI were recruited at Queen Elizabeth Central Hospital in Blantyre, Malawi. Nasopharyngeal swab and urine were collected prior to hospital administered antibiotics. History of antibiotic exposure was obtained by questioning the caregiver and reviewing patient-retained medical records. An optimised urine bioassay was used to detect antimicrobial activity in urine. Pneumococci isolated from nasopharyngeal swabs were tested for antibiotic susceptibility by disc diffusion and E-tests.

resultsAntimicrobial activity from urine specimens were detected in 64% (65/102) of children. Among 29 children with no reported or no recorded pre-admission antibiotic treatment, antimicrobial activity was detected in 11 cases (38%). Among the 73 children with reported antibiotic treatment before admission, 54 (74%) had antimicrobial activity in urine. Pneumococcal carriage prevalence was 63% in children with pre-admission antibiotics based on parent reports and 62% in those without reported pre-treatment. Based on results from the bioassay the pneumococcal prevalence was 57% in children with antimicrobial activity in urine and 73% in those without activity (p = 0.11). No difference was found in the pneumococcal antibiotic susceptibility in children with or without urine antimicrobial activity.

conclusionThis urine bioassay could be a useful and non-invasive tool for objective assessment of pre-clinic antibiotic treatment, as questionnaires can underestimate antibiotic exposure. This could impact surveillance strategies of bacterial carriage prevalences. A short detection period of some antibiotics in urine may limit the use of the bioassay. We found no signs of selection of resistant pneumococcal strains in children with antimicrobial activity in urine.

Indexed as

Anti-Bacterial AgentsBiological AssayCarrier StateDrug Resistance, BacterialPneumococcal InfectionsStreptococcus pneumoniaeChild, PreschoolFemaleHospitalizationHumansInfantMalawiMaleMicrobial Sensitivity TestsNasopharynxPrevalenceAnti-Bacterial AgentsAcute respiratory infectionAntibioticsChildrenStreptococcus pneumoniae

Identifiers

PMID41083965
PMCPMC12516879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.